Trial intelligence / Profile preview

PD-1 inhibitor plus fruquintinib or regorafenib in third-line and later advanced colorectal cancer

ChiCTR2000037752Phase 2Not yet recruiting

Sponsor

Shanghai General Hospital

Start

Jan 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1